Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
66,981
+22,156
+49% +$3.83M 0.05% 357
2026
Q1
$7.58M Buy
44,825
+1,460
+3% +$280K 0.04% 410
2025
Q4
$8.15M Sell
43,365
-612
-1% -$115K 0.04% 359
2025
Q3
$9.05M Buy
43,977
+4,030
+10% +$861K 0.06% 285
2025
Q2
$8.92M Buy
39,947
+18,363
+85% +$3.95M 0.07% 251
2025
Q1
$4.37M Buy
21,584
+4,211
+24% +$839K 0.05% 322
2024
Q4
$3.21M Buy
17,373
+8,631
+99% +$1.81M 0.04% 366
2024
Q3
$1.8M Buy
8,742
+3,542
+68% +$684K 0.03% 384
2024
Q2
$910K Buy
5,200
+1,536
+42% +$262K 0.04% 378
2024
Q1
$629K Buy
+3,664
New +$564K 0.09% 224

Other funds holding CTAS

&Partners's CTAS Position: Q2 2026 in Review

&Partners increased its Cintas (CTAS) stake by 49% in Q2 2026, buying an estimated $3.83M and bringing the position to 66,981 shares worth $11M. The position accounts for 0.05% of the portfolio, ranked #357.

&Partners first reported a position in CTAS in Q1 2024 and has held it in 10 quarters since. 1,428 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • &Partners held 66,981 shares of Cintas worth $11M as of Q2 2026.
  • &Partners bought 22,156 Cintas shares in Q2 2026, an estimated $3.83M.
  • Cintas made up 0.05% of &Partners's portfolio in Q2 2026, its #357 holding.
  • &Partners first reported a position in Cintas in Q1 2024 and has held it in 10 quarters since.
  • 1,428 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.